Vyome Holdings, Inc. (HIND) Presentations https://ir.vyometx.com/news-events/presentations/rss en-us https://d1io3yog0oux5.cloudfront.net/_d024ecc7eca47b6f52a71f1586e4b046/vyometx/files/theme/images/logo-sm.png Vyome Holdings, Inc. Logo Equisolve Investor Relations Suite <![CDATA[VT-1953 in Treating Symptoms of Malignant Fungating Wounds (MFW)]]> https://d1io3yog0oux5.cloudfront.net/_b893180053ef0d8ef07dc282652bdb17/vyometx/db/3576/34489/pdf/VT-1953+Phase+2+Trial+Deck.pdf Thu, 12 Feb 26 00:00:00 -0500 https://d1io3yog0oux5.cloudfront.net/_b893180053ef0d8ef07dc282652bdb17/vyometx/db/3576/34489/pdf/VT-1953+Phase+2+Trial+Deck.pdf <![CDATA[U.S. Market & Product Assessment and Valuation of VT-1953 for the Treatment of Symptoms of Malignant Fungating Wounds H1 2026]]> https://d1io3yog0oux5.cloudfront.net/_b893180053ef0d8ef07dc282652bdb17/vyometx/db/3576/34490/pdf/Vyome_VT1953_Valuation_8K.pdf Tue, 27 Jan 26 00:00:00 -0500 https://d1io3yog0oux5.cloudfront.net/_b893180053ef0d8ef07dc282652bdb17/vyometx/db/3576/34490/pdf/Vyome_VT1953_Valuation_8K.pdf